Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
Coltro G, Capecchi G, Maffioli M, Mannelli F, Mora B, Atanasio A, Iurlo A, Maccari C, Farina M, Nacca E, Caramella M, Signori L, Borella M, Bertù L, Esposito M, Guglielmelli P, Passamonti F, Vannucchi AM.
Coltro G, et al. Among authors: esposito m.
Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285098. Online ahead of print.
Haematologica. 2024.
PMID: 38813708
Free article.